Clinical Trial

Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated November 20, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this clinical trial is to gather information on the safety and effectiveness of botulinum toxin injection (or Botox) in the treatment of thumb joint pain/arthritis. People with thumb joint pain or arthritis usually receive steroid injections to help with the pain. However, this medicine does not always work well and also carries known important side effects. There is currently no alternative to this injection medicine. This clinical trial seeks to investigate botulinum toxin as a possible alternative to steroid injection. The difference between Botox and steroid injections is that they are different medicines and work in different ways. Botox, as it is being used in this study, is not FDA-approved. It is therefore considered an investigational medicine.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-08-10; most recent amendment 2024-11-18.
Trial Details
NCT Number NCT05990881
Lead Sponsor Rhode Island Hospital
Conditions Carpometacarpal Sprain, Thumb Sprain, Clostridium; Botulinum
Enrollment 50 participants
Start Date 2023-08-27
Primary Completion 2025-12 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-11-20